Search Within

Christopher G Azzoli

  1. "Journal of Clinical Oncology"
Formats
  1. Meeting Abstract (31)
  2. Journal Article (6)
Groups
  1. Department of Medicine (32)
  2. Solid Tumor Oncology Division (32)
  3. Thoracic Oncology (30)
  4. Surgery (12)
  5. Survivorship Research (10)
  6. Department of Pathology and Laboratory Medicine (8)

More Groups

People
  1. Mark Kris (30)
  2. Naiyer Rizvi (15)
  3. Vincent Miller (15)
  4. Gregory Riely (10)
  5. Lee Krug (10)
  6. Valerie Rusch (8)

More People

Years
  1. 2014 (1)
  2. 2012 (5)
  3. 2011 (5)
  4. 2010 (4)
  5. 2009 (3)
  6. 2008 (3)

More Years

Publications
  1. Journal of Clinical Oncology (37)
Publishers
  1. American Society of Clinical Oncology (37)

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC
    Meeting Abstract

    Pennell, N. A.; Neal, J. W.; Chaft, J. E.; Azzoli, C. G.; Jänne, P. A.; Govindan, R.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Wakelee, H. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Drilon, A. E. D.; Varghese, A. M.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; Kris, M. G.; Miller, V. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The SELECT study: A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Neal, J. W.; Pennell, N. A.; Govindan, R.; Lanuti, M.; Rosovsky, R. P. G.; Heist, R. S.; Shaw, A. T.; Temel, J. S.; Muzikansky, A.; Janne, P. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Quantitating pathologic response to neoadjuvant chemotherapy in KRAS-mutated versus nonmutated lung cancers
    Meeting Abstract

    Chaft, J. E.; Paik, P. K.; Sima, C. S.; Kris, M. G.; Krug, L. M.; Azzoli, C. G.; Riely, G. J.; Pietanza, M. C.; Rusch, V. W.; Travis, W. D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Prospective study of tumor suppressor gene (TSG) methylation as a prognostic biomarker in surgically resected non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Drilon, A. E. D.; Sugita, H.; Sima, C. S.; Huang, E.; Danenberg, P. V.; Kris, M. G.; Rusch, V. W.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • The SELECT trial: A multicenter phase II trial of adjuvant erlotinib (E) in patients with resected, early-stage non-small cell lung cancer (NSCLC) and confirmed mutations in the epidermal growth factor receptor (EGFR)
    Meeting Abstract

    Pennell, N. A.; Neal, J. W.; Govindan, R.; Janne, P. A.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Lanuti, M.; Azzoli, C. G.; Sequist, L. V.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI
    Meeting Abstract

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; Miller, V. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Results of a randomized phase IIb study estimating overall survival of pralatrexate versus erlotinib in platinum-pretreated NSCLC
    Meeting Abstract

    Patel, J. D.; Azzoli, C. G.; Weems, G. A.; Koutsoukos, A.; Zatloukal, P.; Kelly, K.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Immunogenicity of GI-4000 vaccine in adjuvant consolidation therapy following definitive treatment in patients with stage I-III adenocarcinoma of the lung with G12C, G12D, or G12V KRAS mutations
    Meeting Abstract

    D'Angelo, S. P.; Park, B. J.; Krug, L. M.; Crevar, C.; Medina, C. E.; Sumner, D. K.; Richman, J.; Coeshott, C.; Apelian, D.; Cohn, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save